New Potential Biomarkers to Assess Efficacy of Protection Afforded by Vaccine Candidates Against Tuberculosis
Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2019.02.010
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Elsevier BV